NCT04975633

Brief Summary

A feasibility study investigating the Bodyport virtual cardiac clinic vs usual care for outpatient heart failure management at Keck Medical Center of USC

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable heart-failure

Timeline
Completed

Started May 2021

Typical duration for not_applicable heart-failure

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 10, 2021

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

May 24, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 23, 2021

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 5, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 5, 2024

Completed
Last Updated

February 26, 2025

Status Verified

February 1, 2025

Enrollment Period

3.3 years

First QC Date

May 24, 2021

Last Update Submit

February 23, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in quality of life

    Evaluating Kansas City Cardiomyopathy Questionnaire (KCCQ) measurements at the time of hospital discharge and 90-days post-discharge

    Up to 14 days after enrollment and approximately 90-days post-enrollment

  • Scale Adherence

    Measure of daily scale adherence

    Through study completion, approximately 90 days

Secondary Outcomes (1)

  • Patient and provider satisfaction

    Through study completion, approximately 90 days for patients and an average of 9 months for providers.

Study Arms (2)

BodyPort Cardiac Scale

EXPERIMENTAL

Patient will receive the Bodyport scale with access to Bodyport care services, such as remote monitoring, educational materials, different biomarkers detected by the scale, and online access to their data

Device: Bodyport Cardiac Scale

Control

NO INTERVENTION

Patients will receive usual care and a Bodyport scale that only displays weight and weight change. No other access to care services, features, or materials will be provided during this 90 day period

Interventions

Patients will be instructed to take daily measurements for 90 days. Data will be transmitted to Bodyport and concerning findings (weight gain, change of impedance, elevated heart rate) will be reported back to the medical team. The medical team will either choose to act on the information given or continue to observe trends. Interventions may include titration of therapy, change in therapy, fluid restriction, sodium restriction and lifestyle modification

BodyPort Cardiac Scale

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of HFrEF or HFpEF and hospital discharge for a heart failure exacerbation within 14 days of enrollment.
  • years of age or older
  • English speaking
  • Able to safely stand on the Bodyport scale
  • Patients must have a reliable and working phone for communication with the care team
  • All patients should have access to the internet via a computer or mobile device to access the Bodyport care platform
  • Patients must have a safe and secure place to store the Bodyport device

You may not qualify if:

  • Weight \>375 lbs.
  • History of repeatedly missing follow-up appointments or being unreachable by phone
  • Inability to stand on the Bodyport scale for the duration needed to capture data
  • Patient in jail or currently homeless
  • Known or documented noncompliance with medical therapy
  • Unable to speak English
  • Unable or unwilling to answer survey questions
  • History of heart transplantation
  • Chronic kidney disease stage IV or V and/or on hemodialysis
  • Presence of a ventricular assist device
  • Presence of a CardioMEMs pulmonary artery sensor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Keck Medical Center of USC

Los Angeles, California, 90033, United States

Location

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Michael W Fong, MD

    Keck Medical Center of USC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Clinical Medicine

Study Record Dates

First Submitted

May 24, 2021

First Posted

July 23, 2021

Study Start

May 10, 2021

Primary Completion

September 5, 2024

Study Completion

September 5, 2024

Last Updated

February 26, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations